Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: Vitamin-D2 treatment-associated decrease in 25(OH)D3 level is a reciprocal phenomenon: a randomized controlled trial

Fig. 2

Changes in 25(OH)D2 and 25(OH)D3 levels over 56 days. Data represent mean levels. Error bars represent standard errors of the mean. a and b, study-1: participants were randomized to a single oral dose of 50,000 IU D2 (red squares) or placebo (blue diamond). c and d, study-2: participants were randomized to a single oral dose of 50,000 IU D3 (red squares) or placebo (blue diamond) four days after receiving a single oral dose of 50,000 IU D2. 25(OH)D2, 25-hydroxyvitamin D2. 25(OH)D3, 25-hydroxyvitamin D3. D0, D14, D28, D42, and D56 are day of randomization, and 14, 28, 42, and 56 days after randomization, respectively

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us